FDA Approves First Treatment for Congenital Athymia

Congenital athymia is a rare condition in which babies are born without a thymus. The FDA has approved a tissue culture-derived product for its treatment.

  • Viesearch
    Moderated and indexed this listing ·
  • Anonymous
    Submitted this listing ·

Editorial Actions

Feature Edit